Compare TRVG & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRVG | SLP |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.2M | 250.6M |
| IPO Year | 2015 | 1996 |
| Metric | TRVG | SLP |
|---|---|---|
| Price | $2.78 | $11.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $4.09 | ★ $25.00 |
| AVG Volume (30 Days) | 31.6K | ★ 195.4K |
| Earning Date | 04-28-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | $15.59 | $2.64 |
| Revenue Next Year | $8.42 | $6.01 |
| P/E Ratio | ★ $16.98 | $390.50 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $2.71 | $11.16 |
| 52 Week High | $5.83 | $36.43 |
| Indicator | TRVG | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 33.58 | 32.33 |
| Support Level | N/A | $11.16 |
| Resistance Level | $3.26 | $12.70 |
| Average True Range (ATR) | 0.06 | 0.48 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 0.00 | 14.62 |
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments, namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and all other countries.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.